Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future

References

• Nkengasong JN, Tessema SK. Africa needs a new public health order to tackle infectious disease threats. Cell. 2020;183(2):296–300.
   PubMed Web of Science ®Google Scholar
• Bell D, Schultz Hansen K. Relative burdens of the COVID-19, malaria, tuberculosis, and HIV/AIDS epidemics in sub-Saharan Africa. Am J Trop Med Hyg. 2021;105(6):1510–1515.
   PubMed Web of Science ®Google Scholar
• Dwyer-Lindgren L, Cork MA, Sligar A, et al. Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017. Nature. 2019;570(7760):189–193.
   PubMed Web of Science ®Google Scholar
• Williams PCM, Isaacs D, Berkley JA. Antimicrobial resistance among children in sub-Saharan Africa. Lancet Infect Dis. 2018;18(2):e33–e44.
   PubMed Web of Science ®Google Scholar
• Bernabé KJ, Langendorf C, Ford N, et al. Antimicrobial resistance in West Africa: a systematic review and meta-analysis. Int J Antimicrob Agents. 2017;50(5):629–639.
   PubMed Web of Science ®Google Scholar
• Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629–655. •• Landmark study highlighting the growing importance of AMR as the next pandemic.
   Web of Science ®Google Scholar
• Wamai RG, Hirsch JL, Van Damme W, et al. What could explain the lower COVID-19 burden in Africa despite considerable circulation of the SARS-CoV-2 virus? Int J Environ Res Public Health. 2021;18(16):8638.
   PubMed Web of Science ®Google Scholar
• Mpundu M Moving from paper to action – the status of national AMR action plans in African countries. 2020 [cited 2022 Jun 5]. Available from: https://revive.gardp.org/moving-from-paper-to-action-the-status-of-national-amr-action-plans-in-african-countries/
   Google Scholar
• Collignon P, Beggs JJ, Walsh TR, et al. Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis. Lancet Planet Health. 2018;2(9):e398–e405.
   PubMedGoogle Scholar
• Hendriksen RS, Munk P, Njage P, et al. Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage. Nat Commun. 2019;10(1):1124.
   PubMedGoogle Scholar
• Mabirizi D, Kibuule D, and Adorka M, et al. Promoting the rational medicine use of ARVs. Anti-TB, and Other Medicines and Preventing the Development of Antimicrobial Resistance in Namibia: Workshop and Stakeholders Forum; Namibia. 2013 [cited 2022 Jun 4]. Available from: https://pdf.usaid.gov/pdf_docs/PA00JP4B.pdf
   Google Scholar
• Balala A, Huong TG, Fenwick SG Antibiotics resistance in sub Saharan Africa; literature review from 2010 – 2017. 2020; 37(- 0).
   Google Scholar
• Laxminarayan R, Van Boeckel T, Frost I, et al. The lancet infectious diseases commission on antimicrobial resistance: 6 years later. Lancet Infect Dis. 2020;20(4):e51–e60.
   PubMed Web of Science ®Google Scholar
• Godman B, Haque M, McKimm J, et al. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future. Curr Med Res Opin. 2020;36(2):301–327.
   PubMed Web of Science ®Google Scholar
• Kalungia AC, Burger J, Godman B, et al. Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia. Expert Rev Anti Infect Ther. 2016;14(12):1215–1223.
   PubMed Web of Science ®Google Scholar
• Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control. 2017;6(1):47.
   PubMed Web of Science ®Google Scholar
• Tadesse BT, Ashley EA, Ongarello S, et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis. 2017;17(1):616.
   PubMedGoogle Scholar
• Workneh M, Katz MJ, Lamorde M, et al. Antimicrobial resistance of sterile site infections in sub-Saharan Africa: a systematic review. Open Forum Infect Dis. 2017;4(4):ofx209.
   PubMed Web of Science ®Google Scholar
• Sriram AKE, Kapoor G, Craig J, et al. State of the world’s antibiotics 2021: a global analysis of antimicrobial resistance and its drivers. Washington (DC): Center for Disease Dynamics, Economics & Policy; 2021 [cited 2022 Jun 5]. Available from: https://cddep.org/wp-content/uploads/2021/02/The-State-of-the-Worlds-Antibiotics-in-2021.pdf
   Google Scholar
• Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci U S A. 2018;115(15):E3463–e70.
   PubMed Web of Science ®Google Scholar
• Huemer M, Mairpady Shambat S, Brugger SD, et al. Antibiotic resistance and persistence-Implications for human health and treatment perspectives. EMBO Rep. 2020;21(12):e51034.
   PubMed Web of Science ®Google Scholar
• Asrade B Prevalence of Substandard and Falsified Drugs in Africa; 2021. Available from: https://www.globalpharmacyexchange.org/post/prevalence-of-substandard-and-falsified-drugs-in-africa.
   Google Scholar
• Kelesidis T, Falagas ME. Substandard/counterfeit antimicrobial drugs. Clin Microbiol Rev. 2015;28(2):443–464.
   PubMed Web of Science ®Google Scholar
• WHO. 1 in 10 medical products in developing countries is substandard or falsified; 2017 [cited 2022 Jun 4]. Available from: https://www.who.int/news/item/28-11-2017-1-in-10-medical-products-in-developing-countries-is-substandard-or-falsified
   Google Scholar
• Ghanem N. Substandard and falsified medicines: global and local efforts to address a growing problem. Clin Pharm. 2019;11(5) DOI:10.1211/PJ.2019.20206309.
   Google Scholar
• Tessema GA, Kinfu Y, Dachew BA, et al. The COVID-19 pandemic and healthcare systems in Africa: a scoping review of preparedness, impact and response. BMJ Glob Health. 2021;6(12). 10.1136/bmjgh-2021-007179.
   PubMed Web of Science ®Google Scholar
• Adepoju P. African nations to criminalise falsified medicine trafficking. Lancet. 2020;395(10221):324.
   PubMed Web of Science ®Google Scholar
• WHO. Launch of the Lomé Initiative; 2020 [cited 2022 Jun 4]. Available from: https://www.who.int/dg/speeches/detail/launch-of-the-lom%C3%A9-initiative
   Google Scholar
• Acosta A, Vanegas EP, Rovira J, et al. Medicine shortages: gaps between countries and global perspectives. Front Pharmacol. 2019;10:763.
   PubMed Web of Science ®Google Scholar
• Modisakeng C, Matlala M, Godman B, et al. Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications. BMC Health Serv Res. 2020;20(1):234.
   PubMed Web of Science ®Google Scholar
• Chigome AK, Matlala M, Godman B, et al. Availability and use of therapeutic interchange policies in managing antimicrobial shortages among South African public sector hospitals; Findings and implications. Antibiotics. 2019;9(1):4.
   Google Scholar
• MacPherson EE, Reynolds J, Sanudi E, et al. Understanding antimicrobial resistance through the lens of antibiotic vulnerabilities in primary health care in rural Malawi. Glob Public Health. 2021:1–17. 10.1080/17441692.2021.2015615.
   PubMed Web of Science ®Google Scholar
• Meyer JC, Schellack N, Stokes J, et al. Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; A preliminary study. Front Pharmacol. 2017;8:751.
   PubMed Web of Science ®Google Scholar
• Leung N-HZ, Chen A, Yadav P, et al. The impact of inventory management on stock-outs of essential drugs in sub-Saharan Africa: secondary analysis of a field experiment in Zambia. PLoS One. 2016;11(5):e0156026–e.
   PubMed Web of Science ®Google Scholar
• Godman B, Egwuenu A, Haque M, et al. Strategies to improve antimicrobial utilization with a special focus on developing countries. Life. 2021;11(6):528.
   PubMedGoogle Scholar
• Jansen KU, Anderson AS. The role of vaccines in fighting antimicrobial resistance (AMR). Hum Vaccin Immunother. 2018;14(9):2142–2149.
   PubMed Web of Science ®Google Scholar
• Micoli F, Bagnoli F, Rappuoli R, et al. The role of vaccines in combatting antimicrobial resistance. Nat Rev Microbiol. 2021;19(5):287–302.
   PubMed Web of Science ®Google Scholar
• Cohen R, Cohen JF, Chalumeau M, et al. Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries. Expert Rev Vaccines. 2017;16(6):625–640.
   PubMed Web of Science ®Google Scholar
• Troisi M, Andreano E, Sala C, et al. Vaccines as remedy for antimicrobial resistance and emerging infections. Curr Opin Immunol. 2020;65:102–106.
   PubMed Web of Science ®Google Scholar
• Lewnard JA, Lo NC, Arinaminpathy N, et al. Childhood vaccines and antibiotic use in low- and middle-income countries. Nature. 2020;581(7806):94–99.
   PubMed Web of Science ®Google Scholar
• Bloom DE, Black S, Salisbury D, et al. Antimicrobial resistance and the role of vaccines. Proc Natl Acad Sci U S A. 2018;115(51):12868–12871.
   PubMed Web of Science ®Google Scholar
• Buchy P, Ascioglu S, Buisson Y, et al. Impact of vaccines on antimicrobial resistance. Int J Infect Dis. 2020;90:188–196.
   PubMed Web of Science ®Google Scholar
• Montwedi DNMJ, Nkwinika VV, Burnett RJ. Health facility obstacles result in missed vaccination opportunities in Tshwane region 5, Gauteng province. South Afr J Child Health. 2021;15(3):159–164.
   Web of Science ®Google Scholar
• Muhoza P, Danovaro-Holliday MC, Diallo MS, et al. Routine vaccination coverage - worldwide, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(43):1495–1500.
   PubMed Web of Science ®Google Scholar
• Abbas K, Procter SR, van Zandvoort K, et al. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. Lancet Glob Health. 2020;8(10):e1264–e72.
   PubMed Web of Science ®Google Scholar
• Olorunsaiye CZ, Yusuf KK, Reinhart K, et al. COVID-19 and child vaccination: a systematic approach to closing the immunization gap. Int J MCH AIDS. 2020;9(3):381–385.
   PubMedGoogle Scholar
• Gaythorpe KA, Abbas K, Huber J, et al. Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries. Elife. 2021;10. DOI:10.7554/eLife.67023.
   Web of Science ®Google Scholar
• Lassi ZS, Naseem R, Salam RA, et al. The impact of the COVID-19 pandemic on immunization campaigns and programs: a systematic review. Int J Environ Res Public Health. 2021;18(3):988.
   PubMed Web of Science ®Google Scholar
• Ota MOC, Badur S, Romano-Mazzotti L, et al. Impact of COVID-19 pandemic on routine immunization. Ann Med. 2021;53(1):2286–2297.
   PubMed Web of Science ®Google Scholar
• Roberts L. Pandemic brings mass vaccinations to a halt. Science. 2020;368(6487):116–117.
   PubMed Web of Science ®Google Scholar
• Coker M, Folayan MO, Michelow IC, et al. Things must not fall apart: the ripple effects of the COVID-19 pandemic on children in sub-Saharan Africa. Pediatr Res. 2021;89(5):1078–1086.
   PubMed Web of Science ®Google Scholar
• Jarchow-MacDonald AA, Burns R, Miller J, et al. Keeping childhood immunisation rates stable during the COVID-19 pandemic. Lancet Infect Dis. 2021;21(4):459–460.
   PubMed Web of Science ®Google Scholar
• Rana S, Shah R, Ahmed S, et al. Post-disruption catch-up of child immunisation and health-care services in Bangladesh. Lancet Infect Dis. 2021;21(7):913.
   PubMed Web of Science ®Google Scholar
• Shahwan M, Suliman A, Abdulrahman Jairoun A, et al. Prevalence, knowledge and potential determinants of COVID-19 vaccine acceptability among university students in the United Arab Emirates: findings and implications. J Multidiscip Healthc. 2022;15:81–92.
   PubMed Web of Science ®Google Scholar
• Afolabi AA, Ilesanmi OS. Dealing with vaccine hesitancy in Africa: the prospective COVID-19 vaccine context. Pan Afr Med J. 2021;38:3.
   PubMed Web of Science ®Google Scholar
• Cooper S, van Rooyen H, Wiysonge CS. COVID-19 vaccine hesitancy in South Africa: how can we maximize uptake of COVID-19 vaccines? Expert Rev Vaccines. 2021;20(8):921–933.
   PubMed Web of Science ®Google Scholar
• Mutombo PN, Fallah MP, Munodawafa D, et al. COVID-19 vaccine hesitancy in Africa: a call to action. Lancet Glob Health. 2022;10(3):e320–e1.
   PubMed Web of Science ®Google Scholar
• Anand Paramadhas BD, Tiroyakgosi C, Mpinda-Joseph P, et al. Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications. Expert Rev Anti Infect Ther. 2019;17(7):535–546.
   PubMed Web of Science ®Google Scholar
• Kruger D, Dlamini NN, Meyer JC, et al. Development of a web-based application to improve data collection of antimicrobial utilization in the public health care system in South Africa. Hosp Pract. 2021;49(3):184–193.
   PubMedGoogle Scholar
• Momanyi L, Opanga S, Nyamu D, et al. Antibiotic prescribing patterns at a leading referral hospital in Kenya: a point prevalence survey. J Res Pharm Pract. 2019;8(3):149–154.
   PubMed Web of Science ®Google Scholar
• Skosana PP, Schellack N, Godman B, et al. A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications. Expert Rev Anti Infect Ther. 2021;19(10):1353–1366.
   PubMed Web of Science ®Google Scholar
• Ogunleye OO, Oyawole MR, Odunuga PT, et al. A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications. Expert Rev Anti Infect Ther. 2022;20(2):297–306.
   PubMed Web of Science ®Google Scholar
• D’Arcy N, Ashiru-Oredope D, Olaoye O, et al. Antibiotic prescribing patterns in Ghana, Uganda, Zambia and Tanzania hospitals: results from the global point prevalence survey (G-PPS) on antimicrobial use and stewardship interventions implemented. Antibiotics. 2021;10(9):1122.
   Google Scholar
• Afriyie DK, Sefah IA, Sneddon J, et al. Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship. JAC Antimicrob Resist. 2020;2(1):dlaa001.
   PubMedGoogle Scholar
• Brink AJ, Messina AP, Feldman C, et al. Antimicrobial stewardship across 47 South African hospitals: an implementation study. Lancet Infect Dis. 2016;16(9):1017–1025.
   PubMed Web of Science ®Google Scholar
• Department of Health Republic of South Africa. National infection prevention and control strategic framework. 2020 [cited 2022 Jun 5]. Available from: https://www.nicd.ac.za/wp-content/uploads/2020/04/National-Infection-Prevention-and-Control-Strategic-Framework-March-2020-1.pdf
   Google Scholar
• Nathwani D, Varghese D, Stephens J, et al. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrob Resist Infect Control. 2019;8(1):35.
   PubMedGoogle Scholar
• Akpan MR, Isemin NU, Udoh AE, et al. Implementation of antimicrobial stewardship programmes in African countries: a systematic literature review. J Glob Antimicrob Resist. 2020;22:317–324.
   PubMed Web of Science ®Google Scholar
• Mpinda-Joseph P, Anand Paramadhas BD, Reyes G, et al. Healthcare-associated infections including neonatal bloodstream infections in a leading tertiary hospital in Botswana. Hosp Pract. 2019;47(4):203–210.
   PubMedGoogle Scholar
• Labi AK, Obeng-Nkrumah N, Owusu E, et al. Multi-centre point-prevalence survey of hospital-acquired infections in Ghana. J Hosp Infect. 2019;101(1):60–68.
   PubMed Web of Science ®Google Scholar
• Irek EO, Amupitan AA, Obadare TO, et al. A systematic review of healthcare-associated infections in Africa: an antimicrobial resistance perspective. Afr J Lab Med. 2018;7(2):796.
   PubMed Web of Science ®Google Scholar
• Iwu CD, Patrick SM. An insight into the implementation of the global action plan on antimicrobial resistance in the WHO African region: a roadmap for action. Int J Antimicrob Agents. 2021;58(4):106411.
   PubMed Web of Science ®Google Scholar
• Ariyo P, Zayed B, Riese V, et al. Implementation strategies to reduce surgical site infections: a systematic review. Infect Control Hosp Epidemiol. 2019;40(3):287–300.
   PubMed Web of Science ®Google Scholar
• Mwita JC, Souda S, Magafu M, et al. Prophylactic antibiotics to prevent surgical site infections in Botswana: findings and implications. Hosp Pract. 2018;46(3):97–102.
   PubMedGoogle Scholar
• Cooper L, Sneddon J, Afriyie DK, et al. Supporting global antimicrobial stewardship: antibiotic prophylaxis for the prevention of surgical site infection in low- and middle-income countries (LMICs): a scoping review and meta-analysis. JAC-Antimicrob Resist. 2020;2(3). DOI:10.1093/jacamr/dlaa070.
   Google Scholar
• Mwita JC, Ogunleye OO, Olalekan A, et al. Key issues surrounding appropriate antibiotic use for prevention of surgical site infections in low- and middle-income countries: a narrative review and the implications. Int J Gen Med. 2021;14:515–530.
   PubMed Web of Science ®Google Scholar
• Allegranzi B, Aiken AM, Zeynep Kubilay N, et al. A multimodal infection control and patient safety intervention to reduce surgical site infections in Africa: a multicentre, before-after, cohort study. Lancet Infect Dis. 2018;18(5):507–515.
   PubMed Web of Science ®Google Scholar
• Menz BD, Charani E, Gordon DL, et al. Surgical antibiotic prophylaxis in an era of antibiotic resistance: common resistant bacteria and wider considerations for practice. Infect Drug Resist. 2021;14:5235–5252.
   PubMed Web of Science ®Google Scholar
• Olaru ID, Meierkord A, Godman B, et al. Assessment of antimicrobial use and prescribing practices among pediatric inpatients in Zimbabwe. J Chemother. 2020;32(8):456–459.
   PubMed Web of Science ®Google Scholar
• Sefah IA, Essah DO, Kurdi A, et al. Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: findings and implications for the future. JAC Antimicrob Resist. 2021;3(2):dlab080.
   PubMedGoogle Scholar
• van der Sandt N, Schellack N, Mabope LA, et al. Surgical antimicrobial prophylaxis among pediatric patients in South Africa comparing two healthcare settings. Pediatr Infect Dis J. 2019;38(2):122–126.
   PubMed Web of Science ®Google Scholar
• Niaz Q, Godman B, Campbell S, et al. Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications. Int J Clin Pharm. 2020;42(4):1227–1236.
   PubMed Web of Science ®Google Scholar
• Seni J, Mapunjo SG, Wittenauer R, et al. Antimicrobial use across six referral hospitals in Tanzania: a point prevalence survey. BMJ Open. 2020;10(12):e042819.
   PubMed Web of Science ®Google Scholar
• Ogunleye OO, Fadare JO, Yinka-Ogunleye AF, et al. Determinants of antibiotic prescribing among doctors in a Nigerian urban tertiary hospital. Hosp Pract. 2019;47(1):53–58.
   PubMedGoogle Scholar
• Fadare JO, Ogunleye O, Iliyasu G, et al. Status of antimicrobial stewardship programmes in Nigerian tertiary healthcare facilities: findings and implications. J Glob Antimicrob Resist. 2019;17:132–136.
   PubMed Web of Science ®Google Scholar
• Babatola AO, Fadare JO, Olatunya OS, et al. Addressing antimicrobial resistance in Nigerian hospitals: exploring physicians prescribing behavior, knowledge, and perception of antimicrobial resistance and stewardship programs. Expert Rev Anti Infect Ther. 2021;19(4):537–546.
   PubMed Web of Science ®Google Scholar
• Kalungia AC, Mwambula H, Munkombwe D, et al. Antimicrobial stewardship knowledge and perception among physicians and pharmacists at leading tertiary teaching hospitals in Zambia: implications for future policy and practice. J Chemother. 2019;31(7–8):378–387.
   PubMed Web of Science ®Google Scholar
• Cox JA, Vlieghe E, Mendelson M, et al. Antibiotic stewardship in low- and middle-income countries: the same but different? Clin Microbiol Infect. 2017;23(11):812–818.
   PubMed Web of Science ®Google Scholar
• Hijazi K, Joshi C, Gould IM. Challenges and opportunities for antimicrobial stewardship in resource-rich and resource-limited countries. Expert Rev Anti Infect Ther. 2019;17(8):621–634.
   PubMed Web of Science ®Google Scholar
• Pierce J, Apisarnthanarak A, Schellack N, et al. Global antimicrobial stewardship with a focus on low- and middle-income countries. Int J Infect Dis. 2020;96:621–629.
   PubMed Web of Science ®Google Scholar
• Nampoothiri V, Bonaconsa C, Surendran S, et al. What does antimicrobial stewardship look like where you are? Global narratives from participants in a massive open online course. JAC Antimicrob Resist. 2022;4(1):dlab186.
   PubMedGoogle Scholar
• Yau JW, Thor SM, Tsai D, et al. Antimicrobial stewardship in rural and remote primary health care: a narrative review. Antimicrob Resist Infect Control. 2021;10(1):105.
   PubMed Web of Science ®Google Scholar
• Elton L, Thomason MJ, Tembo J, et al. Antimicrobial resistance preparedness in sub-Saharan African countries. Antimicrob Resist Infect Control. 2020;9(1):145.
   PubMed Web of Science ®Google Scholar
• Engler D, Meyer JC, Schellack N, et al. Compliance with South Africa’s antimicrobial resistance national strategy framework: are we there yet? J Chemother. 2021;33(1):21–31.
   PubMed Web of Science ®Google Scholar
• Majumder MAA, Rahman S, Cohall D, et al. Antimicrobial stewardship: fighting antimicrobial resistance and protecting global public health. Infect Drug Resist. 2020;13:4713–4738.
   PubMed Web of Science ®Google Scholar
• Haque M, Godman B. Potential strategies to improve antimicrobial utilisation in hospitals in Bangladesh building on experiences across developing countries. Bangladesh J Med Sci. 2021;20(3):469–477.
   Web of Science ®Google Scholar
• Sharland M, Pulcini C, Harbarth S, et al. Classifying antibiotics in the WHO essential medicines list for optimal use-be AWaRe. Lancet Infect Dis. 2018;18(1):18–20.
   PubMed Web of Science ®Google Scholar
• Sharland M, Gandra S, Huttner B, et al. Encouraging AWaRe-ness and discouraging inappropriate antibiotic use-the new 2019 essential medicines list becomes a global antibiotic stewardship tool. Lancet Infect Dis. 2019;19(12):1278–1280.
   PubMed Web of Science ®Google Scholar
• Hsia Y, Lee BR, Versporten A, et al. Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries. Lancet Glob Health. 2019;7(7):e861–e71
   PubMed Web of Science ®Google Scholar
• Klein EY, Milkowska-Shibata M, Tseng KK, et al. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data. Lancet Infect Dis. 2021;21(1):107–115.
   PubMed Web of Science ®Google Scholar
• Pauwels I, Versporten A, Drapier N, et al. Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries. J Antimicrob Chemother. 2021;76(6):1614–1624.
   PubMed Web of Science ®Google Scholar
• Sulis G, Adam P, Nafade V, et al. Antibiotic prescription practices in primary care in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2020;17(6):e1003139.
   PubMed Web of Science ®Google Scholar
• Okoth C, Opanga S, Okalebo F, et al. Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: findings and implications. Hosp Pract. 2018;46(3):128–136.
   PubMedGoogle Scholar
• Sulis G, Daniels B, Kwan A, et al. Antibiotic overuse in the primary health care setting: a secondary data analysis of standardised patient studies from India, China and Kenya. BMJ Glob Health. 2020;5(9):e003393.
   PubMed Web of Science ®Google Scholar
• Langford BJ, So M, Raybardhan S, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021;27(4):520–531.
   PubMed Web of Science ®Google Scholar
• Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;71(9):2459–2468.
   PubMed Web of Science ®Google Scholar
• Iwu CJ, Jordan P, Jaja IF, et al. Treatment of COVID-19: implications for antimicrobial resistance in Africa. Pan Afr Med J. 2020;35(Suppl 2):119.
   PubMedGoogle Scholar
• Alshaikh FS, Godman B, Sindi ON, Seaton RA, Kurdi A. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis. PLoS One. 2022;17(8):e0272375
   PubMed Web of Science ®Google Scholar
• Founou RC, Blocker AJ, Noubom M, et al. The COVID-19 pandemic: a threat to antimicrobial resistance containment. Future Sci OA. 2021;7(8):Fso736.
   PubMed Web of Science ®Google Scholar
• Hsu J. How covid-19 is accelerating the threat of antimicrobial resistance. BMJ. 2020;369:m1983.
   PubMedGoogle Scholar
• Cheng LS, Chau SK, Tso EY, et al. Bacterial co-infections and antibiotic prescribing practice in adults with COVID-19: experience from a single hospital cluster. Ther Adv Infect Dis. 2020;7:2049936120978095.
   Web of Science ®Google Scholar
• Goncalves Mendes Neto A, Lo KB, Wattoo A, et al. Bacterial infections and patterns of antibiotic use in patients with COVID-19. J Med Virol. 2021;93(3):1489–1495.
   PubMed Web of Science ®Google Scholar
• Hughes S, Troise O, Donaldson H, et al. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020;26(10):1395–1399.
   PubMed Web of Science ®Google Scholar
• Tiroyakgosi C, Matome M, Summers E, et al. Ongoing initiatives to improve the use of antibiotics in Botswana: university of Botswana symposium meeting report. Expert Rev Anti Infect Ther. 2018;16(5):381–384.
   PubMedGoogle Scholar
• Mathibe LJ, Zwane NP. Unnecessary antimicrobial prescribing for upper respiratory tract infections in children in Pietermaritzburg, South Africa. Afr Health Sci. 2020;20(3):1133–1142.
   PubMed Web of Science ®Google Scholar
• Ocan M, Aono M, Bukirwa C, et al. Medicine use practices in management of symptoms of acute upper respiratory tract infections in children (≤12 years) in Kampala city, Uganda. BMC Public Health. 2017;17(1):732.
   PubMedGoogle Scholar
• Ncube NB, Solanki GC, Kredo T, et al. Antibiotic prescription patterns of South African general medical practitioners for treatment of acute bronchitis. S Afr Med J. 2017;107(2):119–122.
   PubMed Web of Science ®Google Scholar
• Köchling A, Löffler C, Reinsch S, et al. Reduction of antibiotic prescriptions for acute respiratory tract infections in primary care: a systematic review. Implement Sci. 2018;13(1):47.
   PubMed Web of Science ®Google Scholar
• Nair MM, Mahajan R, Burza S, et al. Behavioural interventions to address rational use of antibiotics in outpatient settings of low-income and lower-middle-income countries. Trop Med Int Health. 2021;26(5):504–517.
   PubMed Web of Science ®Google Scholar
• Opanga S, Rizvi N, Wamaitha A, et al. Availability of medicines in community pharmacy to manage patients with COVID-19 in Kenya; Pilot study and implications. Sch Acad J Pharm. 2021;10(3):36–42.
   Google Scholar
• Mukokinya MMA, Opanga S, Oluka M, et al. Dispensing of antimicrobials in Kenya: a cross-sectional pilot study and its implications. J Res Pharm Pract. 2018;7(2):77–82.
   PubMed Web of Science ®Google Scholar
• Kamati M, Godman B, Kibuule D. Prevalence of self-medication for acute respiratory infections in young children in Namibia: findings and implications. J Res Pharm Pract. 2019;8(4):220–224.
   PubMed Web of Science ®Google Scholar
• Kibuule D, Nambahu L, Sefah IA, et al. Activities in Namibia to limit the prevalence and mortality from COVID-19 including community pharmacy activities and the implications. Sch Acad J Pharm. 2021;10(5):82–92.
   Google Scholar
• Mokwele RN, Schellack N, Bronkhorst E, et al. Using mystery shoppers to determine practices pertaining to antibiotic dispensing without a prescription among community pharmacies in South Africa—a pilot survey. JAC-Antimicrob Resist. 2022;4(1). DOI:10.1093/jacamr/dlab196
   PubMedGoogle Scholar
• Morel CM, Alm RA, Årdal C, et al. A one health framework to estimate the cost of antimicrobial resistance. Antimicrob Resist Infect Control. 2020;9(1):187.
   PubMed Web of Science ®Google Scholar
• Mohsin M, Van Boeckel TP, Saleemi MK, et al. Excessive use of medically important antimicrobials in food animals in Pakistan: a five-year surveillance survey. Glob Health Action. 2019;12(sup1):1697541.
   PubMedGoogle Scholar
• Van Boeckel TP, Pires J, Silvester R, et al. Global trends in antimicrobial resistance in animals in low- and middle-income countries. Science. 2019;365(6459). DOI:10.1126/science.aaw1944.
   PubMed Web of Science ®Google Scholar
• Samutela MT, Kwenda G, Simulundu E, et al. Pigs as a potential source of emerging livestock-associated Staphylococcus aureus in Africa: a systematic review. Int J Infect Dis. 2021;109:38–49.
   PubMed Web of Science ®Google Scholar
• McEwen SA, Collignon PJ. Antimicrobial resistance: a one health perspective. Microbiol Spectr. 2018;6(2). DOI:10.1128/microbiolspec.ARBA-0009-2017
   Web of Science ®Google Scholar
• Aidara-Kane A, Angulo FJ, Conly JM, et al. World Health Organization (WHO) guidelines on use of medically important antimicrobials in food-producing animals. Antimicrob Resist Infect Control. 2018;7(1):7.
   PubMedGoogle Scholar
• Kaupitwa CJ, Nowaseb S, Godman B, Kibuule D. Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship. Expert Review of Anti-infective Therapy. 2022 (EPrint).
   Google Scholar
• Van TTH, Yidana Z, Smooker PM, et al. Antibiotic use in food animals worldwide, with a focus on Africa: pluses and minuses. J Glob Antimicrob Resist. 2020;20:170–177.
   PubMed Web of Science ®Google Scholar
• Hofer U. The cost of antimicrobial resistance. Nat Rev Microbiol. 2019;17(1):3.
   PubMedGoogle Scholar
• Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PloS one. 2017;12(12):e0189621.
   PubMed Web of Science ®Google Scholar
• Zhen X, Lundborg CS, Sun X, et al. Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrob Resist Infect Control. 2019;8(1):137.
   PubMed Web of Science ®Google Scholar
• Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903–3910.
   PubMed Web of Science ®Google Scholar
• Cassini A, Högberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.
   PubMed Web of Science ®Google Scholar
• Naylor NR, Atun R, Zhu N, et al. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control. 2018;7(1):58.
   PubMedGoogle Scholar
• Wilson LA, Van Katwyk SR, Weldon I, et al. A global pandemic treaty must address antimicrobial resistance. J Law Med Ethics. 2021;49(4):688–691.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Bornman C, Zafer MM. Antimicrobial resistance threats in the emerging COVID-19 pandemic: where do we stand? J Infect Public Health. 2021;14(5):555–560.
   PubMed Web of Science ®Google Scholar
• Jampani M, Chandy SJ. Increased antimicrobial use during COVID-19: the risk of advancing the threat of antimicrobial resistance. Health Sci Rep. 2021;4(4):e459.
   PubMedGoogle Scholar
• The World Bank. Final report - Drug-resistant infections. A threat to our economic future; 2017 Mar. [cited 2022 Jun 5]. Available from: http://documents1.worldbank.org/curated/en/323311493396993758/pdf/final-report.pdf
   Google Scholar
• Shrestha P, Cooper BS, Coast J, et al. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use. Antimicrob Resist Infect Control. 2018;7(1):98.
   PubMedGoogle Scholar
• Interagency Coordination Group on Antimicrobial Resistance. No time to wait: securing the future from drug-resistant infections - Report to the secretary-General of the united nations; April 2019 [cited 2022 Jun 4]. Available from: https://www.who.int/antimicrobial-resistance/interagency-coordination-group/IACG_final_report_EN.pdf?ua=1
   Google Scholar
• OECD Health Policy Studies, Stemming the Superbug Tide. 2018 [cited 2022 Jun 4]. Available from: https://www.oecd-ilibrary.org/sites/9789264307599-en/index.html?itemId=/content/publication/9789264307599-en&mimeType=text/html
   Google Scholar
• World Health Organisation. Antimicrobial resistance. 2018. [cited 2022 Jun 4]. Available from: http://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
   Google Scholar
• Federal Ministries of Agriculture, Rural Development, Environment and Health, Abuja, Nigeria. National action plan for antimicrobial resistance, 2017–2022; 2017 [cited 2022 Jun 4]. Available from: https://ncdc.gov.ng/themes/common/docs/protocols/77_1511368219.pdf
   Google Scholar
• Saleem Z, Hassali MA, Hashmi FK. Pakistan’s national action plan for antimicrobial resistance: translating ideas into reality. Lancet Infect Dis. 2018;18(10):1066–1067.
   PubMed Web of Science ®Google Scholar
• Fürst J, Čižman M, Mrak J, et al. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Rev Anti Infect Ther. 2015;13(2):279–289.
   PubMed Web of Science ®Google Scholar
• Sartelli M, Catena F, Chichom-Mefire A, et al. Antibiotic use in low and middle-income countries and the challenges of antimicrobial resistance in surgery. Antibiotics. 2020;9(8):497.
   Google Scholar
• Frost I, Van Boeckel TP, Pires J, et al. Global geographic trends in antimicrobial resistance: the role of international travel. J Travel Med. 2019;26(8). DOI:10.1093/jtm/taz036
   PubMed Web of Science ®Google Scholar
• Matee M. Antimicrobial resistance (AMR) at the Southern Africa centre for infectious disease surveillance; 2018 [cited 2022 Jun 5]. Available from: https://www.openaccessgovernment.org/southern-africa-centre-for-infectious-disease/52063/
   Google Scholar
• WHO. Global antimicrobial resistance and use surveillance system (GLASS) report; 2021 [cited 2022 Jun 4]. Available from: https://www.who.int/publications/i/item/9789240027336
   Google Scholar
• World Bank Group. Pulling together to beat superbugs knowledge and implementation gaps in addressing antimicrobial resistance; 2019 [cited 2022 Jun 4]. Available from: https://openknowledge.worldbank.org/bitstream/handle/10986/32552/Pulling-Together-to-Beat-Superbugs-Knowledge-and-Implementation-Gaps-in-Addressing-Antimicrobial-Resistance.pdf?sequence=1&isAllowed=y
   Google Scholar
• WHO. Global action plan on antimicrobial resistance - Report by the Secretariat. 2016 [cited 2022 Jun 5]. Available from: https://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_24-en.pdf
   Google Scholar
• GASPH. Global Antimicrobial Stewardship Partnership Hub; 2022 [cited 2022 Jun 4]. Available from: https://global-asp-hub.com/
   Google Scholar
• BSAC. Global antimicrobial stewardship accreditation scheme; 2021 [cited 2022 Jun 5]. Available from: https://bsac.org.uk/global-antimicrobial-stewardship-accreditation-scheme/
   Google Scholar
• Craig J, Frost I, Sriram A, et al. Development of the first edition of African treatment guidelines for common bacterial infections and syndromes. J Public Health Afr. 2022;12(2). DOI:10.4081/jphia.2021.2009.
   PubMed Web of Science ®Google Scholar
• Africa Centres for Disease Control and Prevention and Center for Disease Dynamics, Economics & Policy. African antibiotic treatment guidelines for common bacterial infections and syndromes - recommended antibiotic treatments in neonatal and pediatric patients; 2021 [cited 2022 Jun 4]. Available from: https://africaguidelines.cddep.org/wp-content/uploads/2021/11/Quick-Reference-Guide_Peds_English.pdf
   Google Scholar
• Africa Centres for Disease Control and Prevention and Center for Disease Dynamics, Economics & Policy. African antibiotic treatment guidelines for common bacterial infections and syndromes - recommended antibiotic treatments in adult patients; 2021 [cited 2022 Jun 4]. Available from: https://africaguidelines.cddep.org/wp-content/uploads/2021/11/Quick-Reference-Guide_Adults_English.pdf
   Google Scholar
• WHO. Global action plan on antimicrobial resistance; 2015 [cited 2022 Jun 4]. Available from: https://apps.who.int/iris/bitstream/handle/10665/193736/9789241509763_eng.pdf?sequence=1
   Google Scholar
• Ghana Ministry of Health, Ministry of Food and Agriculture, Ministry of Environment, Science, Technology and Innovation, Ministry of Fisheries and Aquaculture Development. Ghana National Action Plan for Antimicrobial Use and Resistance; 2017–2021 [cited 2022 Jun 5]. Available from: http://www.moh.gov.gh/wp-content/uploads/2018/04/NAP_FINAL_PDF_A4_19.03.2018-SIGNED-1.pdf
   Google Scholar
• Mendelson M, Matsoso M. The South African antimicrobial resistance strategy framework. AMR Control. 2015;54–61.
   Google Scholar
• Republic of Kenya. National action plan on prevention and containment of antimicrobial resistance, 2017–2022; 2017 [cited 2022 Jun 4]. Available from: https://www.afro.who.int/publications/national-action-plan-prevention-and-containment-antimicrobial-resistance-2017-2022
   Google Scholar
• Ministry of Health and Family Welfare (MoHFW), Government of Bangladesh. National action plan: antimicrobial resistance containment in Bangladesh 2017-’22; 2017 [cited 2022 Jun 4]. Available from: https://www.flemingfund.org/wp-content/uploads/d3379eafad36f597500cb07c21771ae3.pdf
   Google Scholar
• Munkholm L, Rubin O. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans. Global Health. 2020;16(1):109.
   PubMed Web of Science ®Google Scholar
• Saleem Z, Godman B, Azhar F, et al. Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications. Expert Rev Anti Infect Ther. 2022;20(1):71–93.
   PubMed Web of Science ®Google Scholar
• WHO. Call to action on antimicrobial resistance (AMR) – 2021; [cited 2022 Jun 5]. Available from: https://www.un.org/pga/75/wp-content/uploads/sites/100/2021/04/Call-to-Action-on-Antimicrobial-Resistance-AMR-2021.pdf
   Google Scholar
• WHO implementation handbook for national action plans on antimicrobial resistance: guidance for the human health sector; 2022 [cited 2022 Jun 4]. Available from: https://www.who.int/publications/i/item/9789240041981
   Google Scholar
• World Health Organization (WHO), Food and Agriculture Organization of the United Nations (FAO) and World Organisation for Animal Health (OIE). Monitoring global progress on antimicrobial resistance: Tripartite amr country self-assessment survey (TRACSS) 2019-2020 global analysis report; 2021 [cited 2022 Jun 5]. Available from: https://www.who.int/publications/i/item/monitoring-global-progress-on-antimicrobial-resistance-tripartite-amr-country-self-assessment-survey-(tracss)-2019-2020
   Google Scholar
• Essack S. Water, sanitation and hygiene in national action plans for antimicrobial resistance. Bull World Health Organ. 2021;99(8):606–608.
   PubMed Web of Science ®Google Scholar
• Harant A. Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries. Antimicrob Resist Infect Control. 2022;11(1):15.
   PubMed Web of Science ®Google Scholar
• Government of Zimbabwe. The Zimbabwe one health antimicrobial resistance national action plan, 2017-2021; 2017. [cited 2022 Jun 4]. Available from: https://www.flemingfund.org/wp-content/uploads/23599b35adfb6d04c2d3f422d34bcff3.pdf
   Google Scholar
• Opintan JA. Leveraging donor support to develop a national antimicrobial resistance policy and action plan: Ghana’s success story. Afr J Lab Med. 2018;7(2):825.
   PubMed Web of Science ®Google Scholar
• Ogunleye OO, Basu D, Mueller D, et al. Response to the Novel Corona Virus (COVID-19) pandemic across Africa: successes, challenges, and implications for the future. Front Pharmacol. 2020;11:1205.
   PubMed Web of Science ®Google Scholar
• Afriyie DK, Asare GA, Amponsah SK, et al. COVID-19 pandemic in resource-poor countries: challenges, experiences and opportunities in Ghana. J Infect Dev Ctries. 2020;14(8):838–843.
   PubMed Web of Science ®Google Scholar
• Govender NP, Avenant T, Brink A, et al. Federation of infectious diseases societies of Southern Africa guideline: recommendations for the detection, management and prevention of healthcare-associated Candida auris colonisation and disease in South Africa. S Afr J Infect Dis. 2019;34(1):163.
   PubMed Web of Science ®Google Scholar
• Hanin MCE, Queenan K, Savic S, et al. A One Health evaluation of the Southern African Centre for Infectious Disease Surveillance. Front Vet Sci. 2018;5. DOI:10.3389/fvets.2018.00033
   PubMed Web of Science ®Google Scholar
• Chua AQ, Verma M, Hsu LY, et al. An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach. Lancet Reg Health West Pac. 2021;7:100084.
   PubMedGoogle Scholar
• Godman B, Basu D, Pillay Y, et al. Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future. Hosp Pract. 2020;48(2):51–67.
   PubMedGoogle Scholar
• Godman B, Basu D, Pillay Y, et al. Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future. Front Pharmacol. 2020;11:108.
   PubMed Web of Science ®Google Scholar
• Godman B, Leong T, Abubakar AR, et al. Availability and use of long-acting insulin analogues including their biosimilars across Africa: findings and implications. Intern Med. 2021;11:343.
   Google Scholar
• Etando A, Amu AA, Haque M, et al. Challenges and innovations brought about by the COVID-19 pandemic regarding medical and pharmacy education especially in Africa and implications for the future. Healthcare. 2021;9(12):1722.
   Web of Science ®Google Scholar
• Godman B, Grobler C, Van-De-Lisle M, et al. Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. Expert Opin Pharmacother. 2019;20(18):2237–2255.
   PubMed Web of Science ®Google Scholar
• Sefah IA, Ogunleye OO, Essah DO, et al. Rapid assessment of the potential paucity and price increases for suggested medicines and protection equipment for COVID-19 across developing countries with a particular focus on Africa and the implications. Front Pharmacol. 2021;11:588106.
   PubMed Web of Science ®Google Scholar
• World Bank. GDP per capita (US$); 2021 [cited 2022 Jun 4]. Available from: https://data.worldbank.org/indicator/NY.GDP.PCAP.CD
   Google Scholar
• Worldometer. African countries by population 2021 [cited 2022 Jun 4]. Available from: https://www.worldometers.info/population/countries-in-africa-by-population/
   Google Scholar
• FAO, OIE, WHO. Global database for the tripartite antimicrobial resistance (AMR) country self-assessment survey (TrACSS). 2020–2021. Available from: http://amrcountryprogress.org/#/map-view
   Google Scholar
• Mudzikati L, Dramowski A. Neonatal septicaemia: prevalence and antimicrobial susceptibility patterns of common pathogens at Princess Marina Hospital, Botswana. S Afr J Infect Dis. 2015;30(3):108–113.
   Web of Science ®Google Scholar
• Gezmu AM, Bulabula ANH, Dramowski A, et al. Laboratory-confirmed bloodstream infections in two large neonatal units in sub-Saharan Africa. Int J Infect Dis. 2021;103:201–207.
   PubMed Web of Science ®Google Scholar
• Amin ET, Omeichu AA, Shu DM, et al. Control of antimicrobial resistance in Cameroon: feasibility of implementing the National Action Plan. Trop Med Int Health. 2021;26(10):1231–1239.
   PubMed Web of Science ®Google Scholar
• Mouiche MMM, Moffo F, Akoachere JTK, et al. Antimicrobial resistance from a one health perspective in Cameroon: a systematic review and meta-analysis. BMC Public Health. 2019;19(1):1135.
   PubMed Web of Science ®Google Scholar
• Massongo M, Ngando L, Pefura Yone EW, et al. Trends of antibacterial resistance at the national reference laboratory in Cameroon: comparison of the situation between 2010 and 2017. Biomed Res Int. 2021;2021:9957112.
   PubMed Web of Science ®Google Scholar
• Republic of Cameroon Ministry of Public Health. Plan D’action national de lutte contre la resistance aux antimicrobiens - 2018-2020; 2018 [cited 2022 Jun 5]. Available from: http://extwprlegs1.fao.org/docs/pdf/cmr196358.pdf
   Google Scholar
• USAID, SIAPS. Development of Swaziland’s national antimicrobial resistance containment strategic plan. 2018 [cited 2022 Jun 4]. Available from: https://siapsprogram.org/wp-content/uploads/2018/03/18-032-AMR-Technical-Report_Jan2018.-V.4.final_.pdf
   Google Scholar
• Zwane SP, McGee S-AM, Suleman F. A comparative cost analysis of antibiotic treatment for community acquired pneumonia (CAP) in adult inpatients at piggs peak government hospital in Swaziland. Front Public Health [Internet]. 2018;6. DOI:10.3389/fpubh.2018.00303.
   PubMed Web of Science ®Google Scholar
• WHO. Resource mobilisation for antimicrobial resistance (AMR): getting AMR into plans and budgets of government and development partners Ghana country level report; 2018 [cited 2022 Jun 4]. Available at: https://cdn.who.int/media/docs/default-source/antimicrobial-resistance/amr-spc-npm/nap-support-tools/ghana-amr-integration-report-who-june-2018.pdf?sfvrsn=96dcf53b_1&download=true
   Google Scholar
• Labi AK, Obeng-Nkrumah N, Dayie N, et al. Antimicrobial use in hospitalized patients: a multicentre point prevalence survey across seven hospitals in Ghana. JAC Antimicrob Resist. 2021;3(3):dlab087.
   PubMedGoogle Scholar
• Afari-Asiedu S, Oppong FB, Tostmann A, et al. Determinants of inappropriate antibiotics use in rural central Ghana using a mixed methods approach. Front Public Health. 2020;8:90.
   PubMed Web of Science ®Google Scholar
• Koduah A, Gyansa-Lutterodt M, Hedidor GK, et al. Antimicrobial resistance national level dialogue and action in Ghana: setting and sustaining the agenda and outcomes. One Health Outlook. 2021;3(1):18.
   PubMedGoogle Scholar
• Jimah TOO. National action plan on antimicrobial resistance: stakeholder analysis of implementation in Ghana. J Global Health Rep. 2020;4(e2020067):1–16.
   Google Scholar
• Kpokiri EE, Ladva M, Dodoo CC, et al. Knowledge, awareness and practice with antimicrobial stewardship programmes among healthcare providers in a Ghanaian tertiary hospital. Antibiotics. 2022;11(1):6.
   Google Scholar
• Ministry of Health. Ghana national medicines policy 3rd edition 2017-2021; 2017. [cited 2022 Jun 4]. Available from: https://www.moh.gov.gh/wp-content/uploads/2020/07/NMP-book-file-1.pdf
   Google Scholar
• Bediako-Bowan AAA, Owusu E, Labi AK, et al. Antibiotic use in surgical units of selected hospitals in Ghana: a multi-centre point prevalence survey. BMC Public Health. 2019;19(1):797.
   PubMedGoogle Scholar
• Darkwah TO, Afriyie DK, Sneddon J, et al. Assessment of prescribing patterns of antibiotics using National Treatment Guidelines and World Health Organization prescribing indicators at the Ghana Police Hospital: a pilot study. Pan Afr Med J. 2021;39:222.
   PubMed Web of Science ®Google Scholar
• Labi AK, Obeng-Nkrumah N, Sunkwa-Mills G, et al. Antibiotic prescribing in paediatric inpatients in Ghana: a multi-centre point prevalence survey. BMC Pediatr. 2018;18(1):391.
   PubMedGoogle Scholar
• Sunkwa-Mills G, Rawal L, Enweronu-Laryea C, et al. Perspectives and practices of healthcare providers and caregivers on healthcare-associated infections in the neonatal intensive care units of two hospitals in Ghana. Health Policy Plan. 2020;35(Supplement_1):i38–i50.
   PubMedGoogle Scholar
• Opoku MM, Bonful HA, Koram KA. Antibiotic prescription for febrile outpatients: a health facility-based secondary data analysis for the Greater Accra region of Ghana. BMC Health Serv Res. 2020;20(1):978.
   PubMed Web of Science ®Google Scholar
• Hein W, Aglanu LM, Mensah-Sekyere M, et al. Fighting antimicrobial resistance: development and implementation of the Ghanaian national action plan. Antibiotics. 2022;11(5):613.
   Google Scholar
• Ghebrehewet S, Shepherd W, Panford-Quainoo E, et al. Implementation of a delayed prescribing model to reduce antibiotic prescribing for suspected upper respiratory tract infections in a hospital outpatient department, Ghana. Antibiotics. 2020;9(11):773.
   Google Scholar
• Janssen J, Afari-Asiedu S, Monnier A, et al. Exploring the economic impact of inappropriate antibiotic use: the case of upper respiratory tract infections in Ghana. Antimicrob Resist Infect Control. 2022;11(1): 53-. DOI:10.1186/s13756-022-01096-w.
   Web of Science ®Google Scholar
• Omulo S, Oluka M, Ombajo L, et al. Point-prevalence surveys of antibiotic use at three large public hospitals in Kenya. Infect Control Hosp Epidemiol. 2020;41(S1):s353–s4.
   Google Scholar
• Maina M, Mwaniki P, Odira E, et al. Antibiotic use in Kenyan public hospitals: prevalence, appropriateness and link to guideline availability. Int J Infect Dis. 2020;99:10–18.
   PubMed Web of Science ®Google Scholar
• Apondi OE, Oduor OC, Gye BK, et al. High prevalence of multi-drug resistant Klebsiella pneumoniae in a tertiary teaching hospital in western Kenya. Afr J Infect Dis. 2016;10(2):89–95.
   PubMedGoogle Scholar
• Devex. When global health goes local: tackling infectious diseases and antimicrobial resistance in Kenya; 2019 [cited 2022 Jun 5]. Available from: https://www.devex.com/news/sponsored/when-global-health-goes-local-tackling-infectious-diseases-and-antimicrobial-resistance-in-kenya-96029
   Google Scholar
• Rhee C, Aol G, Ouma A, et al. Inappropriate use of antibiotics for childhood diarrhea case management — Kenya, 2009–2016. BMC Public Health. 2019;19(S3):468.
   PubMedGoogle Scholar
• Republic of Kenya. National action plan for the containment and prevention of antimicrobial resistance - Monitoring and evaluation framework; 2021 [cited 2022 Jun 4]. Available from: https://www.health.go.ke/wp-content/uploads/2021/09/National-Action-Plan-for-The-Containment-and-Prevention-of-Antimicrobial-Resistance-Monitoring-and-Evaluation-Framework-2021-2.pdf
   Google Scholar
• Ministry of Health, Kenya. National antimicrobial stewardship - Guidelines for health care settings in Kenya; 2020 [cited 2022 Jun 4]. Available from: https://www.health.go.ke/wp-content/uploads/2021/09/National-Antimicrobial-Stewardship-Guidelines-for-health-care-settings-In-Kenya-2020.pdf
   Google Scholar
• Republic of Kenya Ministry of Health. Kenya National Infection Prevention and Control Strategic Plan for Health Care Services 2021 – 2025; 2021 [cited 2022 Jun 4]. Available from: https://www.health.go.ke/wp-content/uploads/2021/09/Kenya-National-Infection-Prevention-and-Control-Strategic-Plan-for-Health-Care-Services-2021-2025.pdf
   Google Scholar
• Republic of Kenya Ministry of Health. Kenya national infection prevention and control policy for health care services may 2021. Third ed; 2021 [cited 2022 Jun 4]. Available from: https://www.health.go.ke/wp-content/uploads/2021/09/Kenya-National-Infection-Prevention-and-Control-Policy-for-Health-Care-Services-May-2021.pdf
   Google Scholar
• Republic of Kenya Ministry of Health. Diagnostic stewardship - A clinician’s handbook on appropriate use of microbiologic diagnostic tests; 2021 [cited 2022 Jun 4]. Available from: https://www.health.go.ke/wp-content/uploads/2021/09/Clinicians-handbook-on-Diagnostic-Stewardship-2021.pdf
   Google Scholar
• Opanga SA, Mwang’ombe NJ, Okalebo FA, et al. Determinants of the effectiveness of antimicrobial prophylaxis among neurotrauma patients at a referral hospital in Kenya: findings and implications. Infect Dis Preve Med. 2017;5:169.
   Google Scholar
• Hendriksen RS, Lukjancenko O, Munk P, et al. Pathogen surveillance in the informal settlement, Kibera, Kenya, using a metagenomics approach. PLoS One. 2019;14(10):e0222531.
   PubMed Web of Science ®Google Scholar
• Mbugua SM, Njoroge G, Kijogi C, et al. Exploring perspectives on antimicrobial stewardship: a qualitative study of health managers in Kenya. Glob Health Res Policy. 2020;5(1):49.
   PubMedGoogle Scholar
• FAO Regional Office for Africa. World antibiotic awareness week (WAAW) Africa – 2019; 2019 [cited 2022 Jun 5]. Available from: https://www.fao.org/africa/events/detail-events/en/c/1244430/
   Google Scholar
• Mutai WC, Mureithi MW, Anzala O, et al. High prevalence of multidrug-resistant clostridioides difficile following extensive use of antimicrobials in hospitalized patients in Kenya. Front Cell Infect Microbiol. 2020;10:604986.
   PubMed Web of Science ®Google Scholar
• Tornberg-Belanger SN, Rwigi D, Mugo M, et al. Antimicrobial resistance including extended spectrum beta lactamases (ESBL) among E. coli isolated from Kenyan children at hospital discharge. PLoS Negl Trop Dis. 2022;16(3):e0010283.
   PubMed Web of Science ®Google Scholar
• Kibira J, Kihungi L, Ndinda M, et al. Improving hand hygiene practices in two regional hospitals in Kenya using a continuous quality improvement (CQI) approach. Antimicrob Resist Infect Control. 2022;11(1):56.
   PubMed Web of Science ®Google Scholar
• Lord J, Gikonyo A, Miwa A, et al. Antimicrobial resistance among Enterobacteriaceae, Staphylococcus aureus, and Pseudomonas spp. isolates from clinical specimens from a hospital in Nairobi, Kenya. PeerJ. 2021;9:e11958.
   PubMed Web of Science ®Google Scholar
• Maina J, Ndung’u P, Muigai A, et al. Antimicrobial resistance profiles and genetic basis of resistance among non-fastidious Gram-negative bacteria recovered from ready-to-eat foods in Kibera informal housing in Nairobi, Kenya. Access Microbiol. 2021;3(6):000236.
   PubMedGoogle Scholar
• Othieno JO, Njagi O, Azegele A. Opportunities and challenges in antimicrobial resistance behavior change communication. One Health. 2020;11:100171.
   PubMed Web of Science ®Google Scholar
• Government of the republic of Malawi. Antimicrobial Resistance Strategy 2017 – 2022 [cited 2022 Jun 4]. Available from: https://cdn.who.int/media/docs/default-source/antimicrobial-resistance/amr-spc-npm/nap-library/malawi_antimicrobial-resistance-strategy-2017-2022.pdf?sfvrsn=f2b81215_1&download=true
   Google Scholar
• The Fleming Fund. Malawi; 2022.
   Google Scholar
• The Fleming Fund. Fleming Fund to tackle growing threat of drug resistance in Malawi and Zimbabwe; 2020 [cited 2022 Jun 5]. Available from: https://www.flemingfund.org/publications/fleming-fund-to-tackle-growing-threat-of-drug-resistance-in-malawi-and-zimbabwe/
   Google Scholar
• Kayambankadzanja RK, Lihaka M, Barratt-Due A, et al. The use of antibiotics in the intensive care unit of a tertiary hospital in Malawi. BMC Infect Dis. 2020;20(1): 776-. DOI:10.1186/s12879-020-05505-6.
   PubMed Web of Science ®Google Scholar
• USAID, SIAPS. Containing antimicrobial resistance through rational antimicrobial use in Namibia; 2018 [cited 2022 Jun 4]. Available from: https://siapsprogram.org/wp-content/uploads/2018/06/18-068-Technical-report-on-combating-AMR-in-Namibia_FINAL.pdf
   Google Scholar
• Nakwatumbah S, Kibuule D, Godman B, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther. 2017;15(7):713–721.
   PubMed Web of Science ®Google Scholar
• Simeon P, Godman B, Kalemeera F. Antibiotics’ susceptibility patterns of bacterial isolates causing lower respiratory tract infections in ICU patients at referral hospitals in Namibia. Hosp Pract. 2021;49(5):356–363.
   PubMedGoogle Scholar
• Nigeria Centre for Disease Control, WHO. Country-led midterm joint external evaluation of IHR core capacities; 2019 Nov 18 – 22. [cited 2022 Jun 5]. Available from: https://www.ncdc.gov.ng/themes/common/docs/protocols/119_1581414518.pdf
   Google Scholar
• Federal Ministeries of Agriculture, Environment and Health. Antimicrobial Use and Resistance in Nigeria - Situation analysis and recommendations; 2017 [cited 2022 Jun 4]. Available from: https://ncdc.gov.ng/themes/common/docs/protocols/56_1510840387.pdf
   Google Scholar
• WHO. Resource mobilisation for Antimicrobial Resistance (AMR): getting AMR into plans and budgets of government and development partners - Nigeria country level report; 2018 [cited 2022 Jun 4]. Available from: https://www.who.int/antimicrobial-resistance/national-action-plans/Nigeria-AMR-country-level-report-WHO-March-2018.pdf?ua=1
   Google Scholar
• Chukwu EE, Oladele DA, Enwuru CA, et al. Antimicrobial resistance awareness and antibiotic prescribing behavior among healthcare workers in Nigeria: a national survey. BMC Infect Dis. 2021;21(1):22.
   PubMed Web of Science ®Google Scholar
• Jibril AH, Okeke IN, Dalsgaard A, et al. Association between antimicrobial usage and resistance in Salmonella from poultry farms in Nigeria. BMC Vet Res. 2021;17(1): 234-. DOI:10.1186/s12917-021-02938-2.
   PubMed Web of Science ®Google Scholar
• Oloso NO, Fagbo S, Garbati M, et al. Antimicrobial resistance in food animals and the environment in Nigeria: a review. Int J Environ Res Public Health. 2018;15(6):1284.
   Web of Science ®Google Scholar
• Onyegbula J NCDC launches ‘Turn Nigeria Orange’ project; 2019 [cited 2022 Jun 4]. Available from: https://nnn.ng/ncdc-launches-turn-nigeria-orange-project/
   Google Scholar
• Abubakar U. Antibiotic use among hospitalized patients in northern Nigeria: a multicenter point-prevalence survey. BMC Infect Dis. 2020;20(1):86.
   PubMed Web of Science ®Google Scholar
• Adedapo AD, Akunne OO. Patterns of antimicrobials prescribed to patients admitted to a tertiary care hospital: a prescription quality audit. Cureus. 2021;13(6):e15896.
   PubMed Web of Science ®Google Scholar
• Oshikoya KA, Ogunyinka IA, Adamaigbo C, et al. Surgical antimicrobial prophylaxis and its dose appropriateness among paediatric patients in a Nigerian teaching hospital. J Chemother. 2019;31(6):329–342.
   PubMed Web of Science ®Google Scholar
• Olowo-Okere A, Ibrahim YKE, Olayinka BO, et al. Epidemiology of surgical site infections in Nigeria: a systematic review and meta-analysis. Niger Postgrad Med J. 2019;26(3):143–151.
   PubMedGoogle Scholar
• Olowo-Okere A, Ibrahim YKE, Sani AS, et al. Occurrence of surgical site infections at a tertiary healthcare facility in Abuja, Nigeria: a prospective observational study. Med Sci. 2018;6(3):60.
   Google Scholar
• Kazmierczak KM, Rabine S, Hackel M, et al. Multiyear, multinational survey of the incidence and global distribution of metallo-β-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2016;60(2):1067–1078.
   PubMed Web of Science ®Google Scholar
• Labuschagne Q, Schellack N, Gous A, et al. COLISTIN: adult and paediatric guideline for South Africa, 2016. S Afr J Infect Dis. 2016;31(1):3–7.
   Web of Science ®Google Scholar
• Mendelson M, Brink A, Gouws J, et al. The one health stewardship of colistin as an antibiotic of last resort for human health in South Africa. Lancet Infect Dis. 2018;18(9):e288–e94.
   PubMed Web of Science ®Google Scholar
• Skosana PP, Schellack N, Godman B, et al. A national, multicentre, web-based point prevalence survey of antimicrobial use and quality indices among hospitalised paediatric patients across South Africa. J Glob Antimicrob Resist. 2021;29:542–550.
   PubMedGoogle Scholar
• Matsitse TB, Helberg E, Meyer JC, et al. Compliance with the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in South Africa: findings and implications. Expert Rev Anti Infect Ther. 2017;15(10):963–972.
   PubMed Web of Science ®Google Scholar
• Departments of Health and Agriculture, Forestry and fisheries for the republic of South Africa: antimicrobial resistance national strategy framework 2017 – 2024. [cited 2022 Jun 4]. Available from: https://www.knowledgehub.org.za/system/files/elibdownloads/2020-03/AMR%20National%20Action%20Plan%202018%20-%202024.pdf
   Google Scholar
• Department of Health Republic of South Africa. Surveillance for Antimicrobial Resistance; 2020 [cited 2022 Jun 4]. Available from: https://www.knowledgehub.org.za/system/files/elibdownloads/2020-03/Guide%20to%20access%20the%20National%20AMR%20Surveillance%20Dashboard.pdf
   Google Scholar
• Department of Health Republic of South Africa. Practical manual for implementation of the national infection prevention and control strategic framework; 2020 [cited 2022 Jun 4]. Available from: https://www.knowledgehub.org.za/system/files/elibdownloads/2020-04/Practical%20Manual%20for%20implementation%20of%20the%20National%20IPC%20Strategic%20Framework%20March%202020.pdf
   Google Scholar
• Department of Health Republic of South Africa. Guidelines for the prevention and containment of antimicrobial resistance in South African hospitals; 2018 [cited 2022 Jun 4] Availabe at URL: https://www.knowledgehub.org.za/system/files/elibdownloads/2020-03/Guidelines%20for%20the%20prevention%20and%20containment%20of%20AMR%20in%20SA%20hospitals.pdf
   Google Scholar
• Manderson L. Prescribing, care and resistance: antibiotic use in urban South Africa. Humanit Soc Sci Commun. 2020;7(1):77.
   Google Scholar
• Department of Health Republic of South Africa. Become an Antibiotic Guardian; 2022 [cited 2022 Jun 4]. Available from: https://antibioticguardian.com/south-africa/
   Google Scholar
• Mokoena TTW, Schellack N, Brink AJ. Driving antibiotic stewardship awareness through the minibus-taxi community across the Tshwane District, South Africa—a baseline evaluation. JAC Antimicrob Resist. 2021;3(3):dlab106.
   PubMedGoogle Scholar
• Balliram R, Sibanda W, Essack SY. The knowledge, attitudes and practices of doctors, pharmacists and nurses on antimicrobials, antimicrobial resistance and antimicrobial stewardship in South Africa. S Afr J Infect Dis. 2021;36(1):262.
   PubMed Web of Science ®Google Scholar
• Epps A, Albury C, Van Hecke O. Exploring primary care clinicians’ views about how best to implement a potential trial around point-of-care tests for common infections in South Africa. Diagnostics. 2021;11(11):2100.
   Web of Science ®Google Scholar
• Mendelson M There’s another pandemic we should be focused on: antibiotic-resistant infections - Millions of people are now dying every year because of bad practices and South Africa is one of the worst culprits; 2022 [cited 2022 Jun 5]. Available from: https://www.groundup.org.za/article/antibiotic-resistance-pandemic-getting-steadily-worse-we-need-fix-it/
   Google Scholar
• Chetty S, Reddy M, Ramsamy Y, et al. Antimicrobial stewardship in South Africa: a scoping review of the published literature. JAC Antimicrob Resist. 2019;1(3):dlz060.
   PubMedGoogle Scholar
• Ekwanzala MD, Dewar JB, Kamika I, et al. Systematic review in South Africa reveals antibiotic resistance genes shared between clinical and environmental settings. Infect Drug Resist. 2018;11:1907–1920.
   PubMed Web of Science ®Google Scholar
• Gasson J, Blockman M, Willems B. Antibiotic prescribing practice and adherence to guidelines in primary care in the Cape Town Metro District, South Africa. S Afr Med J. 2018;108(4):304–310.
   PubMed Web of Science ®Google Scholar
• Farley E, Stewart A, Davies MA, et al. Antibiotic use and resistance: knowledge, attitudes and perceptions among primary care prescribers in South Africa. S Afr Med J. 2018;108(9):763–771.
   PubMed Web of Science ®Google Scholar
• Koopmans LR, Finlayson H, Whitelaw A, et al. Paediatric antimicrobial use at a South African hospital. Int J Infect Dis. 2018;74:16–23.
   PubMed Web of Science ®Google Scholar
• The united republic of Tanzania ministry of health community development gender elderly and children. The national action plan on antimicrobial resistance 2017 – 2022; 2017 [cited 2022 Jun 4]. Available from: https://cdn.who.int/media/docs/default-source/antimicrobial-resistance/the-national-action-plan-on-antimicrobial-resistance-2017-2022.pdf?sfvrsn=31d0867d_1&download=true
   Google Scholar
• Horumpende PG, Mshana SE, Mouw EF, et al. Point prevalence survey of antimicrobial use in three hospitals in North-Eastern Tanzania. Antimicrob Resist Infect Control. 2020;9(1):149.
   PubMed Web of Science ®Google Scholar
• Sonda TB, Horumpende PG, Kumburu HH, et al. Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania: a need for a hospital antibiotic stewardship programme. PLoS One. 2019;14(8):e0220261.
   PubMed Web of Science ®Google Scholar
• Sangeda RZ, Kibona J, Munishi C, et al. Assessment of implementation of antimicrobial resistance surveillance and antimicrobial stewardship programs in Tanzanian health facilities a year after launch of the national action plan. Front Public Health. 2020;8:454.
   PubMed Web of Science ®Google Scholar
• CDDEP. Uganda releases AMR national action plan; 2019. [cited 2022 Jun 5]. Available from: https://cddep.org/blog/posts/uganda-amr-nap/
   Google Scholar
• Republic of Uganda. Antimicrobial resistance national action plan 2018-2023. [cited 2022 Jun 5]. Available from: https://www.cphl.go.ug/sites/default/files/2020-02/Uganda%20National%20Action%20Plan%20for%20Antimicrobial%20Resistance%202018-%202023-compressed_0.pdf
   Google Scholar
• Odoi ROM. Anti-microbial resistance in Uganda. Africa Health; 2019:28–30 [cited 2022 Jun 4]. Available from: https://africa-health.com/wp-content/uploads/2019/02/AH-JAN-28-30-AMR.pdf
   Google Scholar
• Kiguba R, Karamagi C, Bird SM. Extensive antibiotic prescription rate among hospitalized patients in Uganda: but with frequent missed-dose days. J Antimicrob Chemother. 2016;71(6):1697–1706.
   PubMed Web of Science ®Google Scholar
• Kibuule D, Kagoya HR, Godman B. Antibiotic use in acute respiratory infections in under-fives in Uganda: findings and implications. Expert Rev Anti Infect Ther. 2016;14(9):863–872.
   PubMed Web of Science ®Google Scholar
• Nayiga S, Kayendeke M, Nabirye C, et al. Use of antibiotics to treat humans and animals in Uganda: a cross-sectional survey of households and farmers in rural, urban and peri-urban settings. JAC Antimicrob Resist. 2020;2(4):dlaa082.
   PubMedGoogle Scholar
• Mugerwa I, Nabadda SN, Midega J, et al. Antimicrobial resistance situational analysis 2019-2020: design and performance for human health surveillance in Uganda. Trop Med Infect Dis. 2021;6(4):178.
   Google Scholar
• Kagoya EK, Royen KV, Waako P, et al. Experiences and views of healthcare professionals on the prescription of antibiotics in Eastern Uganda: a qualitative study. J Glob Antimicrob Resist. 2021;25:66–71.
   PubMed Web of Science ®Google Scholar
• Muwanguzi TE, Yadesa TM, Agaba AG. Antibacterial prescription and the associated factors among outpatients diagnosed with respiratory tract infections in Mbarara Municipality, Uganda. BMC Pulm Med. 2021;21(1):374.
   PubMed Web of Science ®Google Scholar
• Nambasa V, Ndagije HB, Serwanga A, et al. Prescription of levofloxacin and moxifloxacin in select hospitals in Uganda: a pilot study to assess guideline concordance. Antibiotics. 2020;9(8):439.
   Google Scholar
• Kiggundu R, Wittenauer R, Waswa JP, et al. Point prevalence survey of antibiotic use across 13 hospitals in Uganda. Antibiotics. 2022;11(2). DOI:10.3390/antibiotics11020199.
   Google Scholar
• Kajumbula H, Fujita AW, Mbabazi O, et al. Antimicrobial drug resistance in blood culture isolates at a tertiary hospital, Uganda. Emerg Infect Dis. 2018;24(1):174–175.
   PubMed Web of Science ®Google Scholar
• Government of the Republic of Zambia. Multi-sectoral national action plan on antimicrobial resistance 2017 – 2027. [cited 2022 Jun 4]. Available from: https://www.afro.who.int/sites/default/files/2018-08/ZNPHI%20Document.pdf
   Google Scholar
• AMRCC, CSE. Zambia’s integrated antimicrobial resistance surveillance framework - January 2020. [cited 2022 Jun 4]. Available from: https://www.afro.who.int/sites/default/files/2020-01/Integrated%20Antimicrobial%20Resistance%20Surveillance%20Framework%20-PRINT%20VERSION.pdf
   Google Scholar
• Chiyangi H, Muma JB, Malama S, et al. Identification and antimicrobial resistance patterns of bacterial enteropathogens from children aged 0-59 months at the University Teaching Hospital, Lusaka, Zambia: a prospective cross sectional study. BMC Infect Dis. 2017;17(1):117.
   PubMedGoogle Scholar
• Masich AM, Vega AD, Callahan P, et al. Antimicrobial usage at a large teaching hospital in Lusaka, Zambia. PLoS One. 2020;15(2):e0228555–e.
   PubMed Web of Science ®Google Scholar
• Roth BM, Laps A, Yamba K, et al. Antibiogram development in the setting of a high frequency of multi-drug resistant organisms at university teaching hospital, Lusaka, Zambia. Antibiotics. 2021;10(7). 10.3390/antibiotics10070782.
   Google Scholar
• Nowbuth AAA, Tazikeng N, Makinde O, et al. Antimicrobial resistance in Zambia: a systematic review. Inter J Infect Dis. 2022;116:S17–S8.
   Web of Science ®Google Scholar
• Mhondoro M, Ndlovu N, Bangure D, et al. Trends in antimicrobial resistance of bacterial pathogens in Harare, Zimbabwe, 2012–2017: a secondary dataset analysis. BMC Infect Dis. 2019;19(1):746.
   PubMed Web of Science ®Google Scholar
• Chimbwanda T Zimbabwe’s Antimicrobial Resistance threat to grow if not tackled in a holistic manner; 2020 [cited 2022 Jun 4]. Available from: https://www.afro.who.int/news/zimbabwes-antimicrobial-resistance-threat-grow-if-not-tackled-holistic-manner
   Google Scholar
• Dixon J, Manyau S, Kandiye F, et al. Antibiotics, rational drug use and the architecture of global health in Zimbabwe. Soc Sci Med. 2021;272:113594.
   PubMed Web of Science ®Google Scholar
• Olaru ID, Kibuule D, Godman B. Implications of antibiotic exposure among children in low-income and middle-income countries. Lancet Infect Dis. 2020;20(2):146–147.
   PubMed Web of Science ®Google Scholar
• Hodobo C One health’ key in Zimbabwe’s fight against antimicrobial resistance. 2020; [cited 2022 Jun 5] Available from: https://www.downtoearth.org.in/blog/africa/-one-health-key-in-zimbabwe-s-fight-against-antimicrobial-resistance-74345
   Google Scholar
• Ngwenya R Drug resistance now a pandemic: Chiwenga. [cited 2021 Dec 16]. Available from: https://dailynews.co.zw/drug-resistance-now-a-pandemic-chiwenga/
   Google Scholar
• Gale NK, Heath G, Cameron E, et al. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(1):117.
   PubMed Web of Science ®Google Scholar
• Allemang B, Sitter K, Dimitropoulos G. Pragmatism as a paradigm for patient-oriented research. Health Expect. 2021;25(1):38–47.
   PubMed Web of Science ®Google Scholar
• Kaushik V, Walsh CA. Pragmatism as a research paradigm and its implications for social work research. Soc Sci. 2019;8(9):255.
   Google Scholar
• Palinkas LA, Horwitz SM, Green CA, et al. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42(5):533–544.
   PubMed Web of Science ®Google Scholar
• Rolfe R Jr., Kwobah C, Muro F, et al. Barriers to implementing antimicrobial stewardship programs in three low- and middle-income country tertiary care settings: findings from a multi-site qualitative study. Antimicrob Resist Infect Control. 2021;10(1):60.
   PubMed Web of Science ®Google Scholar
• Graells T, Lambraki IA, Cousins M, et al. Studying factors affecting success of antimicrobial resistance interventions through the lens of experience: a thematic analysis. Antibiotics. 2022;11(5):639.
   Google Scholar
• Haque M, Abubakar AR, Ogunleye OO, et al. Changes in availability, utilization, and prices of medicines and protection equipment for COVID-19 in an urban population of Northern Nigeria. J Res Pharm Pract. 2021;10(1):17–22.
   PubMed Web of Science ®Google Scholar
• Gad M, Salem A, Oortwijn W, et al. Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: current situation and potential solutions. Front Pharmacol. 2020;11:144.
   PubMed Web of Science ®Google Scholar
• Engler D, Meyer JC, Schellack N, et al. Antimicrobial stewardship activities in public healthcare facilities in South Africa: a baseline for future direction. Antibiotics. 2021;10(8):996.
   Google Scholar
• de Vries EJY, Willems B, Bedeker W, et al. Improving primary care antimicrobial stewardship by implementing a peer audit and feedback intervention in Cape Town community health care centres. SAMJ. 2022;In Print.
   Google Scholar
• Schellack N, Benjamin D, Brink A, et al. A situational analysis of current antimicrobial governance, regulation, and utilization in South Africa. Int J Infect Dis. 2017;64:100–106.
   PubMed Web of Science ®Google Scholar
• van den Bergh D, Brink A. A commitment and call to strengthen and expand qualitative research efforts to improve the impact of antimicrobial stewardship. JAC Antimicrob Resist. 2021;3(4):dlab151.
   PubMedGoogle Scholar
• Schellack N, Bronkhorst E, Coetzee R, et al. SASOCP position statement on the pharmacist’s role in antibiotic stewardship 2018. S Afr J Infect Dis. 2018;33(1):28–35.
   Google Scholar
• Eberle C, Stichling S. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr. 2021;13(1):95.
   PubMed Web of Science ®Google Scholar
• Hartmann-Boyce J, Morris E, Goyder C, et al. Diabetes and COVID-19: risks, management, and learnings from other national disasters. Diabetes Care. 2020;43(8):1695–1703.
   PubMed Web of Science ®Google Scholar
• Mohseni M, Ahmadi S, Azami-Aghdash S, et al. Challenges of routine diabetes care during COVID-19 era: a systematic search and narrative review. Prim Care Diabetes. 2021;15(6):918–922.
   PubMed Web of Science ®Google Scholar
• Chan JCN, Lim LL, Wareham NJ, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2021;396(10267):2019–2082.
   PubMed Web of Science ®Google Scholar
• Ogunnigbo O, Nabiryo M, Atteh M, et al. Exploring the antimicrobial stewardship educational needs of healthcare students and the potential of an antimicrobial prescribing app as an educational tool in selected African countries. Antibiotics. 2022;11(5):691.
   Google Scholar
• Sneddon J, Cooper L, Afriyie DK, et al. Supporting antimicrobial stewardship in Ghana: evaluation of the impact of training on knowledge and attitudes of healthcare professionals in two hospitals. JAC Antimicrob Resist. 2020;2(4):dlaa092.
   PubMedGoogle Scholar
• Mahungu J, Drummond C. Educational resource review: MSD’s the Steward-episode 10-AMS in Africa. JAC Antimicrob Resist. 2021;3(3):dlab138.
   PubMedGoogle Scholar
• Commonwealth Pharmacists Association. Commonwealth partnership for antimicrobial stewardship (CwPAMS) Toolkit; 2020 [cited 2022 Jun 4]. Available from: https://commonwealthpharmacy.org/wp-content/uploads/2021/09/CwPAMS-Toolkit-for-Antimicrobial-Stewardship.pdf
   Google Scholar
• Parveen S, Garzon-Orjuela N, Amin D, et al. Public health interventions to improve antimicrobial resistance awareness and behavioural change associated with antimicrobial use: a systematic review exploring the use of social media. Antibiotics. 2022;11(5):669.
   Google Scholar
• Schellack N, Strydom M, Pepper MS, Herd CL, Hendricks CL, Bronkhorst E, et al. Social Media and COVID-19 - Perceptions and Public Deceptions of Ivermectin, Colchicine and Hydroxychloroquine: Lessons for Future Pandemics. Antibiotics. 2022;11(4):445
   Google Scholar